November 13-14, 2018

Boston, MA, USA

Last years Complement-based Drug Development Summit was the first industry-dedicated meeting that focused on the research and development of therapeutics to inhibit the complement pathway, providing safe and effective cures for a range of disease indications.

Across 3 content-packed days, the field’s thought leaders from Alexion, Ra Pharma, Apellis, GSK, Bioverativ, Alnylam and many more shared their insight and lessons learned, collectively enabling the community to:

  • Standardize Efficacy Assessment: Define the next steps toward achieving standardization of robust, functional assays in order to accurately determine treatment efficacy.
  • Optimize Clinical Trial Design: Analyze methods for improving clinical trial design with case studies in patient recruitment and stratification, targeting, dosing, endpoints and sample handling.
  • Manage Off-Target Effects: Enhance the management of off-target effects and approaches for minimizing infection risk.
  • Achieve Regulatory Approval: Learn how best to navigate the regulatory landscape, examining guidelines and expectations to ensure that drugs gain market approval smoothly.
  • Assess Inhibition Points: Analyze the most effective points of complement inhibition for the treatment of individual diseases and the selection of therapeutic approaches for inhibition.

Join your peers in Boston this November 2018 to gain unique and novel insights into methods to accelerate your complement-based drug development. Register your interest today!

Testimonials from our Past Events in the Cell and Viral Immunotherapy Space:

“Overall an excellent programme with topical presentations and great opportunities to network with leaders in the field. The fact that it was a relatively small meeting with high level people made such interactions possible and made it hugely valuable.” Past CVI Summit Attendee, Virttu Biologics

“This was an amazing meeting with a terrific turnout and engagement by industry. The advances in technology being made and the issues being addressed were extremely eye-opening.” Past CVI Summit Attendee, Prescient Healthcare

“This meeting gathered all experts in the field to share ideas and data. It was quite an eye opener. I feel I came home with excitement and a brand new mind towards my work in the field.” Past CVI Summit Attendee, Pfizer

7997 is for


Media Partner